---
$id: https://graph.org.ai/products/commodity/51112012
$type: Product
source: UNSPSC
code: "51112012"
title: "Afatinib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Afatinib

**UNSPSC Code**: 51112012
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinazoline and antineoplastic agent and tyrosine kinase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 41UD74L59M. European Medicines Agency schedules Afatinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32268. As of Q4 2014, AFATINIB remains the US FDA Preferred Term for this commodity. Afatinib bears US NLM identifiers UMLS ID C1879772 and NCI Concept Code C66940. SMILES: CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.

